Third edition editorial board |
|
viii | |
Contributors |
|
ix | |
Acknowledgements |
|
x | |
Preface |
|
xi | |
|
|
1 | (50) |
|
|
1 | (1) |
|
|
2 | (2) |
|
2.1 Organisation of information in the Guide |
|
|
2 | (1) |
|
2.2 Sources of information and disclaimer |
|
|
3 | (1) |
|
|
4 | (2) |
|
3.1 Responsibilities of professional staff at UCLH |
|
|
4 | (1) |
|
3.2 Preparation of injectable medicines on wards, clinics and departments at UCLH |
|
|
5 | (1) |
|
4 An overview of intravenous therapy |
|
|
6 | (5) |
|
4.1 When is intravenous therapy appropriate? |
|
|
6 | (1) |
|
4.2 Drug factors that influence the choice of route |
|
|
7 | (1) |
|
4.3 Disadvantages of intravenous administration |
|
|
8 | (1) |
|
4.4 Routes of intravenous administration |
|
|
9 | (2) |
|
5 Factors affecting patency of intravenous sites |
|
|
11 | (1) |
|
5.1 Factors increasing failure of intravenous sites |
|
|
11 | (1) |
|
5.2 Factors decreasing failure of intravenous sites |
|
|
11 | (1) |
|
5.3 Occlusion of central venous catheters |
|
|
11 | (1) |
|
6 Methods of intravenous administration |
|
|
12 | (5) |
|
|
12 | (1) |
|
6.2 Intermittent intravenous infusion |
|
|
13 | (1) |
|
6.3 Continuous intravenous infusion |
|
|
13 | (1) |
|
6.4 Preparation and administration of intravenous medicines |
|
|
14 | (1) |
|
6.5 Aseptic non-touch technique (ANTT) |
|
|
15 | (2) |
|
7 Extravasation of injectables: overview and management advice |
|
|
17 | (7) |
|
7.1 Patient factors affecting extravasation |
|
|
17 | (1) |
|
7.2 Medicine factors affecting extravasation |
|
|
17 | (4) |
|
7.3 Administration factors affecting extravasation |
|
|
21 | (1) |
|
7.4 Overall risk for extravasation |
|
|
21 | (1) |
|
7.5 Treatment of extravasation |
|
|
21 | (3) |
|
8 Flushing cannulae, catheters and administration sets |
|
|
24 | (2) |
|
8.1 Flushing between medicines |
|
|
24 | (1) |
|
|
24 | (1) |
|
8.3 Flushing catheters and cannulae not in use |
|
|
25 | (1) |
|
8.4 Flushing with heparin |
|
|
25 | (1) |
|
|
26 | (3) |
|
|
26 | (1) |
|
|
26 | (1) |
|
|
26 | (1) |
|
9.4 Pumps for ambulatory use |
|
|
27 | (1) |
|
9.5 Patient-controlled analgesia (PCA) pumps |
|
|
27 | (1) |
|
9.6 Target-controlled anaesthesia (TCI or TIVA) pumps |
|
|
28 | (1) |
|
10 Administration of injectables in primary care |
|
|
29 | (2) |
|
10.1 Self-caring patients |
|
|
30 | (1) |
|
11 Formulation and presentation of injectables |
|
|
31 | (3) |
|
11.1 Medicines that require reconstitution |
|
|
31 | (1) |
|
11.2 Preparations in solution requiring further dilution before use |
|
|
32 | (1) |
|
11.3 Preparations available `ready to use' without further dilution |
|
|
32 | (1) |
|
11.4 Preparations available `ready to administer' |
|
|
32 | (2) |
|
12 Pharmaceutical aspects of injectable administration |
|
|
34 | (3) |
|
|
34 | (1) |
|
|
34 | (1) |
|
|
35 | (1) |
|
|
35 | (1) |
|
|
35 | (2) |
|
13 Factors influencing medicine stability and compatibility of injectable medicines |
|
|
37 | (4) |
|
|
37 | (1) |
|
|
38 | (1) |
|
13.3 Binding of medicines to plastics |
|
|
38 | (1) |
|
13.4 Destabilisation of parenteral emulsions |
|
|
39 | (1) |
|
13.5 Leaching of plasticisers |
|
|
39 | (1) |
|
13.6 Blood and blood products |
|
|
40 | (1) |
|
14 Allergic reactions to injectables |
|
|
41 | (2) |
|
|
41 | (2) |
|
15 Compatibility of drugs in a syringe driver for subcutaneous use |
|
|
43 | (2) |
|
16 Risk assessment of injectables and risk reduction |
|
|
45 | (4) |
|
|
45 | (2) |
|
|
47 | (2) |
|
|
49 | (2) |
|
|
49 | (1) |
|
|
50 | (1) |
|
|
51 | (1) |
User guide |
|
51 | (16) |
Monographs in alphabetical order |
|
67 | (266) |
Index of monographs |
|
333 | |